One step closer to influenza vaccine inclusiveness.
Pediatr Allergy Immunol
; 31 Suppl 26: 69-71, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-1160691
ABSTRACT
Flu virus infection is a common cause of acute respiratory illness, with the major incidence in pediatric age, high morbidity, and mortality. The flu vaccine is recommended for all people aged ≥6 months, unless specific contraindications are present. Younger and older age, pregnancy, chronic diseases like asthma, and immunodeficiency are risk factors for severe complications following flu infection. Thus, these categories represent the target for flu vaccine strategies in most countries. Inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV) or live-attenuated influenza virus (LAIV) are currently available, with specific precautions and contraindications. We aim to resume the current indications for vaccines in the vulnerable populations to support flu vaccination inclusiveness, in anticipation of a "universal vaccine" strategy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Asthma
/
Influenza Vaccines
/
Influenza, Human
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Aged
/
Child
/
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
Pediatr Allergy Immunol
Journal subject:
Allergy and Immunology
/
Pediatrics
Year:
2020
Document Type:
Article
Affiliation country:
Pai.13338
Similar
MEDLINE
...
LILACS
LIS